Login / Signup
Dongshan Zhu
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Pi K Akt
Cell Cycle
Endoplasmic Reticulum Stress
Top Venues
Thoracic cancer
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jingyao Dong
,
Dongshan Zhu
,
Mengmeng Chen
,
Taiwei Wang
,
Yan Gao
,
Wei Liu
Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.
Thoracic cancer
13 (10) (2022)